Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000225314) titled 'ASPiRATION-2 Liquid: An observational cohort study to assess the impact of longitudinal molecular profiling using circulating tumour DNA (ctDNA) in patients with advanced Non-Small Cell Lung Cancer (NSCLC) after failure of genomically targeted therapy' on Feb. 24.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Primary Sponsor: The University of Sydney
Condition:
Advanced Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Cancer - Lung - Non small cell
Intervention:
Molecular profiling usi...